Investigation: Joint Commission rarely revokes accreditation from hospitals that put patients at risk

Hospital lobby
An investigation found that the Joint Commission rarely revokes accreditation from hospitals that put patients at risk. (Getty/monkeybusinessimages)

Though the Joint Commission is the accrediting organization for a vast majority of U.S. hospitals, it rarely revokes that seal of approval for facilities out of compliance with Medicare rules, according to a new investigation.

The Wall Street Journal dug into Joint Commission inspection reports from 2014 through 2016. In 2014, about 350 hospitals with Joint Commission accreditation were in violation of Medicare requirements that year, and about a third of those facilities went on to have additional violations in 2014, 2015 and 2016. About 80% of U.S. hospitals are accredited by the commission.


2019 Drug Pricing and Reimbursement Stakeholder Summit

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape. This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

The Joint Commission revoked accreditation for just 1% of hospitals out of compliance with Medicare. More than 30 hospitals retained their accreditations even though the Centers for Medicare & Medicaid Services determined that their violations were significant enough to cause, or likely cause, serious patient injury or death.

“It’s clearly a failed system and time for a change,” said Ashish Jha, M.D., a health policy researcher at Harvard’s T.H. Chan School of Public Health and a practicing internist.  He added that the investigation “shows accreditation is basically meaningless—it doesn’t mean a hospital is safe.”

RELATED: The upside of surprise Joint Commission surveys? Lower patient death rates

Mark Chassin, M.D., CEO of the Joint Commission, told the WSJ that the commission does not routinely revoke accreditation because its focus is more on preventing incidents than on penalizing hospitals. The group’s mission, he said, is to “work closely with health-care organizations to help them improve the care they provide.”

Federal health officials decided against making accreditors release secret inspection reports. CMS pitched the controversial idea in April but decided not to make the records public last month. About 90% of hospitals are overseen directly by accreditors like the Joint Commission.

The commission argued that the federal proposal would increase costs and hinder patient safety. CMS’ decision to back down was criticized by watchdog organizations like The Leapfrog Group.

The Joint Commission includes some details from its inspections publicly online, but details are scant, even for organizations that received a “preliminary denial of accreditation."

Suggested Articles

CMS Administrator Seema Verma said it will be crucial to have more conversations on how to address emerging—and expensive—therapies. 

We need our federal programs and policies to reflect the goal of improving the health of both women and men.

The political jockeying over "Medicare for All" continued Wednesday as a House committee hosted a second hearing on single-payer healthcare.